Table 3.
Follow-up results of participants in the TRF-GP pilot study 2019.
| Female (n = 31) | Male (n = 9) | Total (n = 40) | |
|---|---|---|---|
| Weight, kg M (SD) | 82.3 (18.5) 1 | 103.7 (24.7) | 87.1 (21.7) |
| Waist circumference, cm M (SD) | 99.4 (12.7) | 109.2 (17.4) | 101.6 (14.2) |
| BMI, kg/m2 M (SD) | 30.4 (6.1) | 31.5 (5.9) | 30.7 (6.0) |
| WHtR, M (SD) | 0.61 (0.07) | 0.60 (0.09) | 0.61 (0.08) |
| Normal weight, n (%) | 9 (29.0) | 1 (11.1) | 10 (25.0) |
| Overweight, n (%) | 6 (19.4) | 3 (33.3) | 9 (22.5) |
| Obesity, n (%) | 16 (51.6) | 5 (55.6) | 21 (52.5) |
| Abdominal obesity, n (%) | 29 (93.5) | 8 (88.9) | 37 (92.5) |
| HbA1c, mmol/mol | 35.2 (4.1) | 38.7 (7.8) | 36.0 (5.3) |
| LDL, mmol/L M (SD) | 3.6 (1.1) | 3.0 (1.2) | 3.5 (1.2) |
| HDL, mmol/l M (SD) | 1.5 (0.3) 2 | 1.0 (0.3) | 1.4 (0.4) |
| TCHOL, mmol/L M (SD) | 5.6 (1.3) | 4.8 (1.2) | 5.4 (1.3) |
| Triglycerides, mmol/L M (SD) | 1.2 (0.8) 3 | 2.0 (1.4) | 1.4 (1.0) |
| hsCRP, nmol/L M (SD) * | 2.63 (2.43) | 2.28 (2.74) | 2.55 (2.47) |
| Δ Weight, kg M (SD) | −1.93 (1.93) | −0.92 (4.05) | −1.71 (2.53) a1 |
| Δ Waist circumference, cm M (SD) | −5.29 (3.15) | −5.12 (3.12) | −5. 26 (3.10) a1 |
| Δ BMI, M (SD) | −1.01 (0.75) | −0.32 (1.27) | − 0.64 (0.89) a1 |
| Δ WHtR, M (SD) | −0.03 (0.02) | −0.03 (0.02) | − 0.03 (0.02) a1 |
| Δ HbA1c, mmol/mol M (SD) | −1.4 (2.4) | −1.7 (6.0) | −1.4 (3.5) a2 |
| Δ LDL, mmol/L M (SD) | 0.2 (0.5) | 0.2 (0.4) | 0.2 (0.5) |
| Δ HDL, mmol/L M (SD) | 0.0 (0.1) | 0.1 (0.1) | 0.0 (0.1) |
| Δ TCHOL, mmol/L M (SD) | 0.0 (0.4) | 0.1 (0.3) | 0.0 (0.4) |
| Δ Triglycerides, mmol/L M (SD) | 0.0 (0.4) | −0.1 (1.3) | 0.0 (0.7) |
| Δ hsCRP, nmol/L M (SD) * | −0.10 (1.86) | 0.82 (3.05) | 0.11 (2.18) |
NOTE: TRF = time-restricted feeding; GP = general practitioner; M = mean; SD = standard deviation; kg = kilogram; cm = centimeter; BMI = body mass index; WHtR = waist-to-height ratio; HbA1c = glycosylated hemoglobin; LDL = low density lipoprotein; HDL = high density lipoprotein; TCHOL = total cholesterol, hsCRP = high-sensitivity C-reactive protein; * 1 value excluded; significant values are bold; 1 p = 0.024, 2 p = 0.001, 3 p = 0.018; Δ = differences between baseline and follow-up; a significance of differences between baseline and follow-up, a1 p < 0.001, a2 p = 0.003.